骨髓增殖性瘤的演变来自正常的血液干细胞
Sahand Hormoz1, Vijay G Sankaran2, Ann Mullally3
1Department of Systems Biology, Harvard Medical School, Boston, MA, USA; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA. sahand_hormoz@hms.harvard.edu.
Haematologica
|December 5, 2024
概括
基因组研究揭示了髓增殖性瘤 (MPN) 发育的几十年前临床阶段,从造血干细胞的突变开始. 了解生殖系变异和克隆进化为个性化MPN疗法和预防铺平了道路.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 在过去的十年中,基因组研究揭示了髓增殖性瘤 (MPN) 的早期病原体.
- 一个临床前阶段,称为克隆性血液形成,先于公开的MPN,从突变获得到疾病发展的间隔为数十年.
- 已经确定了影响MPN风险和造血干细胞生物学的生殖系变异.
研究的目的:
- 审查最近在理解MPN从正常血液形成的致病性方面取得的进展.
- 突出基因组研究,克隆造血和生殖系变异在MPN发展中的作用.
- 讨论MPN个性化医疗和早期干预的未来方向.
主要方法:
- 对正常人血液形成的基因组研究的审查.
- 对MPN发展的谱系追踪研究的分析.
- 检查MPN风险变异的全基因组关联研究.
- 评估研究克隆造血和干细胞适应性的方法.
主要成果:
- 在MPN中识别了长达数十年的临床前阶段 (克隆性血液形成).
- 发现影响MPN风险和造血干细胞生物学的生殖系变异.
- 了解MPN临床异质性的生物学基础的进展.
结论:
- 关于生殖系贡献者和MPN中克隆扩张的未来量化,仍然存在重大知识差距.
- 个性化遗传评估有望预测MPN轨迹并指导治疗.
- 更多地了解MPN演变为早期治疗干预和预防提供了机会.
相关概念视频
Production of Formed Elements
1.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.3K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Overview of Hematopoiesis
3.8K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.8K


